Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD

Clinical trial NCT06243640 · RECRUITING

Trial details

NCT number: NCT06243640
Sponsor: Beijing Union Pharmaceutical Factory Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2023-07-25
Primary completion: 2026-06-30
Enrollment: 504

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.